January 27, 2023
Ozempic is a medication that’s designed to help manage insulin levels in people with type 2 diabetes. However, it’s recently gotten attention after some people spoke out on social media about using the drug for weight loss.
Ozempic, which is a brand name for semaglutide, is currently on the Food and Drug Administration’s list of drug shortages and many have pointed the finger at people using the medication off-label for weight loss as the reason it’s hard to find at the moment. Now, there are reports of another controversy surrounding Ozempic and similar drugs: it may make your face look gaunt.
Fat in the face helps us maintain a naturally youthful appearance. When you lose facial fat, the face often appears gaunt and skeletonized, especially in people who lose large amounts of weight.
Ozempic is an injectable medication that’s designed to be used along with a diet and exercise program to help regulate blood sugar levels in adults with type 2 diabetes when other medications don’t manage blood effectively enough.
Ozempic is technically only approved by the FDA to treat type 2 diabetes. However, research on Ozempic and similar medications has shown weight loss as a common side effect, and fellow semaglutide medication Wegovy is approved to treat weight loss as well. There is another semaglutide medication—called Mounjaro—which is approved to treat diabetes. Clinical trials found people with diabetes who took the medication lost about 12 pounds more than those on other drugs like Ozempic.
The Ozempic website clearly states that this is “not a weight loss drug” but notes that people taking the medication have lost up to 14 pounds.
Want More Details About The Weight Loss Drugs Market?
Then obtain a copy of one of Marketdata’s in-depth market research studies, such as: “The U.S. Weight Loss & Diet Control Market”, or “2022 Status Report of the U.S. Weight Loss Market”. In-depth profiles of Jenny, Weight Watchers, NutriSystem, Medifast, Noom, Profile by Sanford, Herbalife, Lindora Clinics, Atkins, Slim-Fast and others include actual or estimated revenues, programs, history, strategies, advertising, and other key metrics, as well as analysis of the commercial and medical weight loss market segments, and dieter demographics. See: marketdataenterprises.com/studies for report descriptions and Tables of Contents.
Need Custom Research or Consulting?
Yes, Marketdata provides that too. We’ve tracked and analyzed the weight loss market for 34 years since 1989. NO ONE knows more about the nuances of the U.S. weight loss market. Give us a call, speak to John LaRosa, Research Director and head Consultant, at: 813-971-8080. No fee for initial call.